News

Genetic Testing Guidelines for Patients With Breast Cancer

Treatments and Mortality Among Female Childhood Cancer Survivors With Subsequent Breast Cancer

NATALEE Trial: Ribociclib Plus NSAI in Node-Negative Breast Cancer Subgroup

Easing the Effects of T-DXd: Electronic Symptom Tracking Tested in PRO-DUCE Trial

Potential Prognostic Cellular Biomarker Investigated for Stage I Triple-Negative Breast Cancer

Genomic Alterations and Targeted Treatment by Race in Metastatic Breast Cancer

Palbociclib-Based Therapy for HER2-Positive and PAM50 Luminal Advanced Breast Cancer

Antibody-Drug Conjugate ARX788 Under Study in HER2-Positive Breast Cancer

Breast Cancer Treatment: FDA Approves Liquid Form of Thiotepa

ASCO 2024: Targeted Triplet for Leptomeningeal Metastasis in HER2-Positive Breast Cancer

ASCO 2024: Should PI3K Inhibitor Become Part of Standard of Care for Breast Cancer Subtype?

ASCO 2024: Prognostic Value of Hormone Receptor Status and Tumor Subtypes in BRCA-Positive Breast Cancer

Advanced Breast Cancer: Is Abemaciclib Plus Endocrine Therapy of Benefit After Disease Progression?

ASCO 2024: Adjuvant Use of Avelumab in High Risk, Early-Stage Triple-Negative Breast Cancer

ASCO 2024: Phase II Survival Update of Palbociclib Plus Exemestane in Metastatic Breast Cancer

ASCO 2024: MUC1 Vaccine Plus Neoadjuvant Chemotherapy for Early-Stage Breast Cancer

ASCO 2024: Prognostic Role of ctDNA in the monarchE Breast Cancer Trial Population

ASCO 2024: Results From EV-202 of Enfortumab Vedotin in Breast Cancer Cohorts

ASCO 2024: Taxane-Free First-Line Regimen for Advanced HER2-Positive Breast Cancer

ASCO 2024: Is Adjuvant Endocrine Therapy Necessary for ER-Low Breast Cancer?

ASCO 2024: Novel Antibody-Drug Conjugate Under Study in Advanced Triple-Negative Breast Cancer

ASCO 2024: Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer

ASCO 2024: DESTINY-Breast06 Update on T-DXd vs Chemotherapy in Metastatic Breast Cancer

Use of Everolimus in Advanced ER-Positive, HER2-Negative Breast Cancer: Molecular Features Influence Prognosis

ASCO 2024: Longest Reported Follow-up of Fertility and Pregnancy Among Survivors of Breast Cancer

Final ASCENT Trial Results: Sacituzumab Govitecan vs Chemotherapy in Triple-Negative Breast Cancer

Predicting a Woman’s Likelihood of Developing Breast Cancer: Focus on Polygenic Risk Scores

Final Recommendation Statement From USPSTF on Breast Cancer Screening

Clinical Effects of Breast-Conserving Therapy for BRCA-Mutated Disease

Coping With Fibrosis in the Years After Breast-Conserving Therapy

Early-Stage Triple-Negative Breast Cancer: Race and Pathologic Complete Response to Neoadjuvant Treatment

Technology-Based Program for Asian American Breast Cancer Survivors

Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Does Presenting Stage Impact Overall Survival?

Breast Cancer Survivors and Risk for Primary Lung Cancer

Triple-Negative Breast Cancer: Aurora Kinase Inhibition and Neoadjuvant Chemotherapy

Predicting Responses to Chemotherapy-Free Neoadjuvant Therapy in Early-Stage Breast Cancer

AACR 2024: Immunostimulatory Properties of Low-Dose Chemotherapy in Triple-Negative Breast Cancer

AACR 2024: Response to Aromatase Inhibitors in ER-Positive Breast Cancer

AACR 2024: New-Generation PARP Inhibitor Under Study in HER2-Negative Breast Cancer

ASBrS 2024: How Will the Decline of Surgical Reimbursements Impact Breast Cancer Care?

AACR 2024: Novel Compounds May Target MIEN1 Pathway to Treat Breast Cancer

Retrospective Study Offers Insight Into Possible Overuse of Axillary Surgery

AACR 2024: DARPP-32 Protein and Progression of Breast Cancer

AACR 2024: Study Finds Potentially Targetable Mechanistic Pathway in Breast Cancer

AACR 2024: Classifying Patients With Triple-Negative Breast Cancer Based on Cellular Biomarkers

SSO 2024: De-escalation of Locoregional Therapy for Ductal Carcinoma in Situ

SSO 2024: Changes in Biomarker Profiles After Neoadjuvant Therapy for Breast Cancer

Can MRI Surveillance Reduce Breast Cancer Mortality in Women With BRCA1/2 Variations?

Identifying Residual Nodal Disease After Neoadjuvant Therapy for Breast Cancer: Focus on Clipped Axillary Node

EBCC 2024: Atezolizumab Plus Adjuvant Chemotherapy for Triple-Negative Breast Cancer

Cryoablation for Large Breast Tumors: An Alternative to Surgery for Some Patients?

SSO 2024: Nodal Isolated Tumor Cells and Axillary Dissection in Breast Cancer

Study Identifies Novel Therapeutic Targets for Males With Breast Cancer

Are Unmet Social Needs Linked to the Use of Breast Cancer Screening Mammography?

Australian Study Investigates Who May Safely Omit Postoperative Radiotherapy for Early Breast Cancer

Long-Term Update on Role of Adjuvant Abemaciclib Plus Endocrine Therapy for Early Breast Cancer

Not All Triple-Negative Breast Cancers Are Created Equal: Focus on Subtyping-Based Therapy

Novel Androgen Receptor Modulator, Enobosarm, Enters Breast Cancer Treatment Arena

Simulation Models Show Breast Cancer Screening and Treatment Advances Are Saving Lives

A Single-Port Robotic System for Nipple-Sparing Mastectomy

Final Overall Survival Analysis From PALOMA-2: Palbociclib Plus Letrozole in Advanced Breast Cancer

21-Gene Score in Ethnically Diverse, ER-Positive Breast Cancer: Implications for Young Non-Hispanic Black Women

Interrupting Breast Cancer Therapy to Attempt Pregnancy: Use of Assisted Reproductive Technologies

How Common Is Alpelisib-Induced Hyperglycemia in Metastatic Breast Cancer?